Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis (Q38957716)

8 September 2017

Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis (English)

1 reference

8 September 2017

0 references

1 reference

0 references

Anna M Friedhuber

1

1 reference

8 September 2017

Vijay Chandolu

2

1 reference

8 September 2017

Somkamon Manchun

3

1 reference

8 September 2017

Osaana Donkor

4

1 reference

8 September 2017

Pornsak Sriamornsak

5

1 reference

8 September 2017

Crispin R Dass

6

1 reference

8 September 2017

11 September 2014

1 reference

Journal of Pharmacy and Pharmacology

8 September 2017

1 reference

8 September 2017

67

1 reference

8 September 2017

1

1 reference

8 September 2017

68-77

1 reference

Cancer, chitosan nanoparticles and catalytic nucleic acids.

8 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Review: doxorubicin delivery systems based on chitosan for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Novel therapeutic strategy for osteosarcoma targeting osteoclast differentiation, bone-resorbing activity, and apoptosis pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

The molecular pathogenesis of osteosarcoma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

A microsphere-liposome (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFβ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Advance in chitosan hydrolysis by non-specific cellulases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Proteasome is a carrier to translocate doxorubicin from cytoplasm into nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

The human nuclear pore complex as revealed by cryo-electron tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Nuclear penetration of surface functionalized gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Direct observation of nanoparticle-cancer cell nucleus interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

From bench to the clinic: gamma-linolenic acid therapy of human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Bronchoscopic intratumoral chemotherapy of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Head and neck cancer: response to p53-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Induction of colorectal tumors in rats by sulfated polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Liposomes containing cationic dimethyl dioctadecyl ammonium bromide: formulation, quality control, and lipofection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

A nanoparticulate system that enhances the efficacy of the tumoricide Dz13 when administered proximal to the lesion site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12322

21 January 2018

Identifiers

DOI

10.1111/JPHP.12322

1 reference

8 September 2017

1 reference